Global Endometriosis Market 2014-2018 http://www.reportlinker.com/p01361309/Global-Endometriosis-Market-2014-2018.html
Advertisement
About EndometriosisEndometriosis is a common female health condition where the endometrial tissue, which is usually found inside the lining of the uterus, appear and grows outside the uterine cavity. Endometriosis mostly occurs in the fallopian tubes, ovaries, outer surface of the uterus, pelvic cavity, vagina, cervix, and bladder. Endometriosis has rarely been reported in more distant parts of the body such as the lungs, brain, and skin. The most common symptoms associated with endometriosis are pelvic pain, dysmenorrhea, excessive bleeding, and lower abdominal pain. Some of the uncommon symptoms of endometriosis are rectal bleeding and hematuria. The detection of endometriosis in women is difficult because of the common symptoms associated with it. Endometriosis can be diagnosed by laparoscopy, ultrasound, pelvic exam, and biopsy of the inner lining of the uterus. In a biopsy, the tissues from the inner lining of the uterus of the patient are taken and tested using the biomarkers for the presence of endometriosis. Endometriosis is an incurable disease and relapses after the primary treatment. Currently, the treatment options for endometriosis include the usage of hormone therapy and analgesics to control the disease. TechNavio's analysts forecast the Global Endometriosis market will grow at a CAGR of 2.86 percent over the period 2013-2018.
Advertisement
Covered in this Report: This report covers the present scenario and the growth prospects of the Global Endometriosis market for the period 2013-2018. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of endometriosis that are available in the market.TechNavio's report, the Global Endometriosis Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC regions; it also covers the Global Endometriosis market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions• Americas • EMEA • APAC
Key Vendors• Abbvie Inc.• AstraZeneca plc• Bayer AG• Pfizer Inc.
Other Prominent Vendors• Astellas Pharma Inc.• Abbvie Inc.• Repros Therapeutics Inc.• Sanofi SA• Takeda Pharmaceuticals Co. Ltd.
Key Market Driver• High Unmet Needs in the Market• For a full, detailed list, view our report.Key Market Challenge• Patent Expiries of Approved Drugs• For a full, detailed list, view our report.Key Market Trend• Expected Launch of High-cost Therapies• For a full, detailed list, view our report.Key Questions Answered in this Report• What will the market size be in 2018 and what will the growth rate be?• What are the key market trends?• What is driving this market?• What are the challenges to market growth?• Who are the key vendors in this market space?• What are the market opportunities and threats faced by the key vendors?• What are the strengths and weaknesses of the key vendors?You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.
01. Executive Summary02. List of Abbreviations03. Scope of the Report03.1 Market Overview03.2 Product Offerings03.2.1 Product Profiles04. Market Research Methodology04.1 Market Research Process04.2 Research Methodology05. Introduction06. Market Landscape06.1 Market Overview06.2 Market Size and Forecast06.3 Five Forces Analysis07. Rate of Incidence and Prevalence08. Market Segmentation by Type of Therapy08.1.1 Hormone Therapy08.1.2 Analgesics09. Market Segmentation by Route of Administration and Type of Dosage Form09.1.1 Oral09.1.2 Parenteral09.1.3 Topical10. Pipeline Portfolio11. Geographical Segmentation12. Buying Criteria13. Market Growth Drivers14. Drivers and their Impact15. Market Challenges16. Impact of Drivers and Challenges17. Market Trends18. Trends and their Impact19. Vendor Landscape19.1 Competitive Scenario19.1.1 Key News19.2 Market Share Analysis 201319.3 Other Vendors20. Key Vendor Analysis20.1 AbbVie Inc.20.1.1 Key Facts20.1.2 Business Description20.1.3 Product Segmentation20.1.4 Revenue by Product Line20.1.5 Revenue Comparison 2012 and 201320.1.6 Revenue by Geographical Segmentation20.1.7 Business Strategy20.1.8 Key Developments20.1.9 SWOT Analysis20.1.10 Strengths20.1.11 Weaknesses20.1.12 Opportunities20.1.13 Threats20.2 AstraZeneca plc20.2.1 Key Facts20.2.2 Business Overview20.2.3 Business Segmentation20.2.4 Business Strategy20.2.5 Revenue by Business Segmentation20.2.6 Revenue Comparison 2011-201320.2.7 Sales by Geography20.2.8 Key Developments20.2.9 SWOT Analysis20.2.10 Strengths20.2.11 Weaknesses20.2.12 Opportunities20.2.13 Threats20.3 Bayer AG20.3.1 Key Facts20.3.2 Business Overview20.3.3 Business Segmentation20.3.4 Business Strategy20.3.5 Sales Segmentation by Business20.3.6 Sales by Geographical Segmentation20.3.7 Key Information20.3.8 SWOT Analysis20.3.9 Strengths20.3.10 Weaknesses20.3.11 Opportunities20.3.12 Threats20.4 Pfizer Inc.20.4.1 Key Facts20.4.2 Business Overview20.4.3 Business Segmentation by Revenue 201320.4.4 Business Segmentation by Revenue 2012 and 201320.4.5 Sales by Geography20.4.6 Business Strategy20.4.7 Key Developments20.4.8 SWOT Analysis20.4.9 Strengths20.4.10 Weaknesses20.4.11 Opportunities20.4.12 Threats21. Other Reports in this Series
List of Exhibits: Exhibit 1: Market Research MethodologyExhibit 2: Global Endometriosis Market 2013-2018 (US$ million)Exhibit 3: Global Endometriosis Market by Type of TherapyExhibit 4: Global Endometriosis Market Segmentation by Type of Therapy 2013Exhibit 5: Global Endometriosis Market by Route of Administration and Type of Dosage FormExhibit 6: Pipeline Portfolio of the Drugs for EndometriosisExhibit 7: Global Endometriosis Market by Geographical Segmentation 2013Exhibit 8: AbbVie Inc.: Product SegmentationExhibit 9: AbbVie Inc.: Revenue by Product Line 2013Exhibit 10: AbbVie Inc.: Revenue Comparison by Product Line 2012 and 2013 (US$ billion)Exhibit 11: AbbVie Inc.: Revenue by Geographical Segmentation 2013Exhibit 12: AstraZeneca plc: Business SegmentationExhibit 13: AstraZeneca plc: Business Segmentation by Revenue 2013Exhibit 14: AstraZeneca plc: Business Segmentation by Revenue 2011-2013 (US$ billion)Exhibit 15: AstraZeneca plc: Sales by Geography 2013Exhibit 16: Business Segmentation of Bayer AG 2013Exhibit 17: Sales Comparison of Bayer AG by Business Segment 2012 and 2013 (US$ million)Exhibit 18: Sales Segmentation of Bayer AG by Geography 2013Exhibit 19: Pfizer Inc.: Business Segmentation by Revenue 2013Exhibit 20: Pfizer Inc.: Business Segmentation by Revenue 2012 and 2013Exhibit 21: Pfizer Inc.: Sales by Geography 2013
To order this report: Global Endometriosis Market 2014-2018 http://www.reportlinker.com/p01361309/Global-Endometriosis-Market-2014-2018.html
__________________________Contact Clare: [email protected] US: (339)-368-6001Intl: +1 339-368-6001
SOURCE Reportlinker
